MILWAUKEE, June 12, 2023 /PRNewswire/ — Ademi LLP is investigating Chinook (Nasdaq: KDNY) for possible breaches of fiduciary duty and other violations of law in its transaction with Novartis. Click here to learn how to join the action https://www.ademilaw.com/case/chinook-therapeutics-inc or call Guri Ademi toll-free at 866-264-3995. There is no cost…Read More
Shareholder Alert Ademi LLP investigates whether Chinook Therapeutics Inc has obtained a Fair Price in its transaction with Novartis MarketScreener
